Neurocardiovascular pathology in pre-manifest and early-stage Huntington's disease.

Elena Bellosta-DiagoJ Pérez-PérezS Santos LasaosaA Viloria AlebesqueS Martínez-HortaJ KulisevskyJ López Del Val

Published in: European journal of neurology (2018)

These results suggest that higher cardiovascular risks and target-organ damage are present even in pre-manifest patients. Although larger studies are needed to confirm these findings, clinicians should consider these results in the cardiovascular management of patients with HD.

Keyphrases

early stage
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
oxidative stress
prognostic factors
squamous cell carcinoma
radiation therapy
risk assessment
patient reported outcomes
human health
sentinel lymph node